CMA
BIIB icon

Cedar Mountain Advisors’s Biogen BIIB Stock Holding History

Cedar Mountain Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.83K Hold
27
– – ﹤0.01% 646
2026
Q1 		$4.95K Buy
+27
New +$4.97K ﹤0.01% 660
2021
Q1 		– Sell
-1
Closed – – 273
2020
Q4 		$0 Hold
1
– – ﹤0.01% 267
2020
Q3 		$0 Buy
+1
New +$279 ﹤0.01% 252

Other funds holding BIIB

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Cedar Mountain Advisors's BIIB Position: Q2 2026 in Review

Cedar Mountain Advisors held its Biogen (BIIB) position steady in Q2 2026 at 27 shares worth $5.83K. The position accounts for ﹤0.01% of the portfolio, ranked #646.

Cedar Mountain Advisors first reported a position in BIIB in Q3 2020 and has held it in 4 quarters since. 141 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Cedar Mountain Advisors held 27 shares of Biogen worth $5.83K as of Q2 2026.
  • Cedar Mountain Advisors left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #646 holding.
  • Cedar Mountain Advisors first reported a position in Biogen in Q3 2020 and has held it in 4 quarters since.
  • 141 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.